Hereditary Cancer Syndromes

2 researchers across 1 institution

2 Researchers
1 Institutions
0 Grant PIs
0 High Impact

This research area investigates the genetic basis of inherited predispositions to cancer. Studies focus on identifying specific gene mutations associated with hereditary cancer syndromes, understanding how these mutations influence cancer development and progression, and developing strategies for risk assessment and early detection. Methodologies include genetic sequencing, bioinformatics analysis, population genetics, and clinical studies to evaluate the penetrance and expressivity of these genetic alterations. Research also examines the psychological and social impact of genetic testing for cancer risk on individuals and families.

Given Arkansas's demographic profile and health landscape, this research holds significant relevance. Understanding hereditary cancer patterns within the state can inform targeted public health initiatives and screening programs, particularly in communities with potentially higher prevalence of certain genetic mutations. This work contributes to improving cancer outcomes and reducing the burden of the disease across Arkansas by enabling personalized risk management and prevention strategies tailored to the state's population.

This field draws on expertise from genomics, genetic counseling, and public health. Connections are also made to health policy, healthcare management, and the use of electronic health records for data analysis and patient management. Engagement spans multiple institutions within Arkansas, fostering collaborative approaches to addressing complex challenges in hereditary cancer research.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Melinda E. Simonson UAMS 3 30
John F. Jenkins UAMS 3 45

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
7,370 works in 2025
+2.4% CAGR 2018–2025
Leadership concentration
5.7% held by global top 5 institutions
Fragmented HHI 25
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 2,512
  2. 2 Harvard University 2,112
  3. 3 Memorial Sloan Kettering Cancer Center 1,969
  4. 4 Johns Hopkins University 1,624
  5. 5 National Cancer Institute 1,510
Browse All 2 Researchers in Directory